Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

ClinicalTrials.gov ID: NCT05381948

Public ClinicalTrials.gov record NCT05381948. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Prospective, Randomized, Double-Masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects With Wet AMD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2 randomized, double -masked study comparing the efficacy of EYP-1901 at 2 dose levels: 2060 microgram (mcg) and 3090 mcg against aflibercept.

Study identification

NCT ID
NCT05381948
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
EyePoint Pharmaceuticals, Inc.
Industry
Enrollment
161 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2022
Primary completion
Nov 28, 2023
Completion
Apr 23, 2024
Last update posted
Oct 14, 2025

2022 – 2024

United States locations

U.S. sites
67
U.S. states
25
U.S. cities
67
Facility City State ZIP Site status
EyePoint Investigative Site Phoenix Arizona 85053
EyePoint Investigative Site Springdale Arkansas 72762
EyePoint Investigative Site Beverly Hills California 90211
EyePoint Investigative Site Campbell California 95008
EyePoint Investigative Site Encino California 91436
EyePoint Investigative Site Fullerton California 92835
EyePoint Investigative Site Glendale California 91203
EyePoint Investigative Site Huntington Beach California 92647
EyePoint Investigative Site Irvine California 92697
EyePoint Investigative Site Pasadena California 91107
EyePoint Investigative Site Poway California 92064
EyePoint Investigative Site Redlands California 92373
EyePoint Investigative Site Sacramento California 95825
EyePoint Investigative Site Walnut Creek California 94598
EyePoint Investigative Site Lakewood Colorado 80228
EyePoint Investigative Site Clearwater Florida 33761
EyePoint Investigative Site Coral Springs Florida 33067
EyePoint Investigative Site Lakeland Florida 33805
EyePoint Investigative Site Melbourne Florida 32901
EyePoint Investigative Site Miami Florida 33143
EyePoint Investigative Site Pensacola Florida 32503
EyePoint Investigative Site Sarasota Florida 34239
EyePoint Investigative Site St. Petersburg Florida 33711
EyePoint Investigative Site Tampa Florida 33609
EyePoint Investigative Site Winter Haven Florida 33880
EyePoint Investigative Site Marietta Georgia 30060
EyePoint Investigative Site ‘Aiea Hawaii 96701
EyePoint Investigative Site Chicago Illinois 60616
EyePoint Investigative Site Lemont Illinois 60439
EyePoint Investigative Site Carmel Indiana 46290
EyePoint Investigative Site West Des Moines Iowa 50266
EyePoint Investigative Site Baltimore Maryland 21209
EyePoint Investigative Site Hagerstown Maryland 21740
EyePoint Investigative Site Owings Mills Maryland 21117
EyePoint Investigative Site Boston Massachusetts 02114
EyePoint Investigative Site Springfield Massachusetts 01107
EyePoint Investigative Site Grand Rapids Michigan 49446
EyePoint Investigative Site Saint Louis Michigan 55416
EyePoint Investigative Site St Louis Missouri 63128
EyePoint Investigative Site Reno Nevada 89502
EyePoint Investigative Site Teaneck New Jersey 07666
EyePoint Investigative Site Great Neck New York 11021
EyePoint Investigative Site Hauppauge New York 11788
EyePoint Investigative Site Liverpool New York 13088
EyePoint Investigative Site Shirley New York 11967
EyePoint Investigative Site Asheville North Carolina 28803
EyePoint Investigative Site Wake Forest North Carolina 27587
EyePoint Investigative Site Eugene Oregon 97401
EyePoint Investigative Site Portland Oregon 97239
EyePoint Investigative Site Springfield Oregon 97488
EyePoint Investigative Site Charleston South Carolina 29414
EyePoint Investigative Site West Columbia South Carolina 29169
EyePoint Investigative Site Germantown Tennessee 38138
EyePoint Investigative Site Nashville Tennessee 37203
EyePoint Investigative Site Abilene Texas 79606
EyePoint Investigative Sites Austin Texas 78750
EyePoint Investigative Site Dallas Texas 75231
EyePoint Investigative Sites Houston Texas 77025
EyePoint Investigative Site McAllen Texas 78503
EyePoint Investigative Site Plano Texas 75075
EyePoint Investigative Site San Antonio Texas 78240
EyePoint Investigative Site The Woodlands Texas 77384
EyePoint Investigative Site Salt Lake City Utah 84107
EyePoint Investigative Site Fairfax Virginia 22031
EyePoint Investigative Site Lynchburg Virginia 24502
EyePoint Investigative Site Warrenton Virginia 20186
EyePoint Investigative Site Silverdale Washington 98383

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05381948, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05381948 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →